Skip to content

All recalls FDA

FDAMedical devicesRecalled Status: Ongoing

Siemens Healthcare Diagnostics, Inc. recalls Atellica CH Urine Albumin REF: 11537225

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Processing of urine albumin assay on the CI analyzers may lead to the following issues: Falsely depressed Atellica CH Urea Nitrogen (UN_c) results; Falsely depressed Atellica CH Enzymatic Hemoglobin A1c (A1c_E) results; Increased rate of reaction cuvette QC failures and Delayed results due to QC failures.
Products
  • Atellica CH Urine Albumin REF: 11537225
Where it was sold

Worldwide distribution - US Nationwide including Puerto Rico and the countries of Australia, Austria, Bahamas, Belgium, Brazil, Canada, Chile, Curacao, St. Eus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Ireland, Israel,¿Italy,¿Latvia, Malaysia, Netherlands, New Zealand, Norway, Portugal, Republic of Korea, Romania, Singapore, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, United¿Kingdom.¿

Nationwide

Barcodes
00630414611099
Units affected
7018 units
About this recall
Atellica CH Urine Albumin REF: 11537225, in vitro diagnostic